Bioorganic chemistry

International journal of molecular sciences

Frontiers in immunology

journal of infection and public health

Antiviral research

[1] Mapping the Interactions of HBV cccDNA with Host Factors.

[2] Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.

[3] Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines.

[4] Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.

[5] Response: Providing strong evidence of nosocomial outbreak of hepatitis B virus infection

[6] screening and evaluation of chronic and occult hepatitis b in chemo – radiotherapy patients with cancer

[7] características da reação tipo 1 e associação com vírus b e c da hepatite na hanseníase type 1 reaction in leprosy: characteristics and association with hepatitis b and c viruses

[8] occult hepatitis b virus infection in liver transplant patients in a brazilian referral center

[9] regression of esophageal varices during entecavir treatment in patients with hepatitis-b-virus-related liver cirrhosis

[10] epidemiology and molecular characterization of hepatitis b virus in luanda, angola

[11] antiviral activity of a nanoemulsion of polyprenols from ginkgo leaves against influenza a h3n2 and hepatitis b virus in vitro

[12] prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with hiv, tuberculosis, and hepatitis virus

[13] detection of hepatitis b virus antigens in paraffin-embedded liver specimens from the amazon region, brazil

[14] the exposure rate to hepatitis b and c viruses among medical waste handlers in three government hospitals, southern ethiopia

[15] c-myc—making liver sick: role of c-myc in hepatic cell function, homeostasis and disease

[16] high level of hbv dna virus in the breast milk seems not to contraindicate breastfeeding

[17] hgv-hcv/hbv co-infection in india: a pilot study

[18] efficacy and safety of telbivudine in preventing mother-to-infant transmission of hbv in pregnant women with high hbv dna load

[19] a role for the host dna damage response in hepatitis b virus cccdna formation—and beyond?

[20] spanish multicentre pibhe study: prevalence and immunisation of chronic hepatitis b in haemodialysis patients in spain

[21] the immune response of vaccination against hepatitis b virus in iranian patients undergoing chemotherapy

[22] a novel assay for detecting the mutation of nucleotide 1758-1777 deletion in core promoter region of hepatitis b virus

[23] prevalence of hepatitis b and hepatitis c virus co-infection in india: a systematic review and meta-analysis

[24] a cross section study to determine the prevalence of antibodies against hiv infection among hepatitis b and c infected individuals

[25] alta prevalencia de la infección por el virus de hepatitis b en la comunidad indígena japreira, estado zulia, venezuela high prevalence of hepatitis b infection in amerindians in japreira, zulia state, venezuela

[26] upregulated expression of a unique gene by hepatitis b x antigen promotes hepatocellular growth and tumorigenesis

[27] comparison of fibrotest-actitest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis b and c

[28] o vírus da hepatite b na doença hepática alcoólica: avaliação clínica e bioquímica

[29] viral hepatitis infection and insulin resistance: a review of the pathophysiological mechanisms hepatitis virales y resistencia a la insulina: revisión de los mecanismos fisiopatológicos

[30] sensitivity of individual and mini-pool nucleic acid testing assessed by dilution of hepatitis b nucleic acid testing yield samples

[31] <title language="por">hepatitis b and c in the hemodialysis unit of tocantins, brazil: serological and molecular profiles

[32] complete remission of nephrotic syndrome of hepatitis b virus-associated membranous glomerulopathy after lamivudine monotherapy

[33] maternal transmission risk and antibody levels against hepatitis b virus e antigen in pregnant women

[34] value of model for end-stage liver disease score combined with neutrophil-lymphocyte ratio in predicting the short-term prognosis of patients with hbv-related acute-on-chronic liver failure

[35] Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.

[36] Gold nanoparticles and hepatitis B virus

[37] Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

[38] Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

[39] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[40] Seroprevalence of Hepatitis B Virus and Associated Factors among Health Professionals in University of Gondar Hospital, Northwest Ethiopia

[41] Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

[42] Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

[43] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[44] Hepatitis B virus infection: Epidemiology and seroprevalence rate amongst Negrito tribe in Malaysia.

[45] Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.

[46] Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection

[47] Association of rs10204525 genotype GG and rs2227982 CC combination in programmed cell death 1 with hepatitis B virus infection risk.

[48] Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.

[49] Targeting Hepatitis B Virus cccDNA and HBx: Recent Advances and New Approaches.

[50] Surveillance and impact of occult hepatitis B virus, SEN virus, and Torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection.

[51] Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.

[52] Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

[53] Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.

[54] Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection

[55] One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor

[56] Response: Providing strong evidence of nosocomial outbreak of hepatitis B virus infection

[57] Application of Hepatitis B Virus Genotyping and Phylogenetic Analysis in Intrafamilial Transmission of Hepatitis B Virus

[58] Impact of HEC72702 chirality on the selective inhibition of hepatitis B virus capsid dimer: A dynamics-structure-energetics perspective

[59] Simultaneous Acute Hepatitis B Virus and Hepatitis C Virus Infection Leading to Fulminant Hepatitis and Subsequent Chronic Hepatitis C

[60] selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis b virus-infected patients

[61] stimulation of cellular proliferation by hepatitis b virus x protein

[62] survey of both hepatitis b virus (hbsag) and hepatitis c virus (hcv-ab) coinfection among hiv positive patients

[63] conhecimento dos obstetras sobre a transmissão vertical da hepatite b knowledge of obstetricians about the vertical transmission of hepatitis b virus

[64] ethanol extract from ampelopsis sinica root exerts anti-hepatitis b virus activity via inhibition of p53 pathway in vitro

[65] hepatitis b virus vaccination of voluntary blood donors and immunization status assessment by anti-hepatitis b surface (hbs) antibody titer

[66] occult hepatitis b virus infection in liver transplant patients in a brazilian referral center

[67] common mutations of hepatitis b virus and their clinical significance

[68] epidemiology and molecular characterization of hepatitis b virus in luanda, angola

[69] occult hepatitis b virus infections (often with human herpesvirus 7 co-infection) detected in pityriasis rosea patients: a pilot study

[70] identifying and characterizing interplay between hepatitis b virus x protein and smc5/6

[71] tlr2 expression in peripheral cd4+ t cells promotes th17 response and is associated with disease aggravation of hepatitis b virus-related acute-on-chronic liver failure

[72] detection of hepatitis b virus antigens in paraffin-embedded liver specimens from the amazon region, brazil

[73] Quasispecies pattern of hepatitis B virus predicts hepatocellular carcinoma using deep-sequencing and machine learning.

[74] hepatitis b virus genotype e detected in brazil in an african patient who is a frequent traveler

[75] prevalence of occult hepatitis b virus infection in a cohort of hiv-positive patients resident in sicily, italy

[76] translational research on traditional chinese medicine in patients with hepatitis b virus-related liver cirrhosis via treatment with nucleotide analogues

[77] a role for the host dna damage response in hepatitis b virus cccdna formation—and beyond?

[78] the immune response of vaccination against hepatitis b virus in iranian patients undergoing chemotherapy

[79] evaluating the immunity against hepatitis b virus among yasuj university of medical sciences students-2014

[80] efficacy of immunization against hepatitis b virus infection in acute leukemia

[81] acute exacerbation in chronic hepatitis b virus infection

[82] hepatitis b virus dynamics: modeling, analysis, and optimal treatment scheduling

[83] research progress in metabolic activity of natural killer cells in patients with chronic hepatitis b virus infection

[84] a novel assay for detecting the mutation of nucleotide 1758-1777 deletion in core promoter region of hepatitis b virus

[85] an epidemiological serosurvey of hepatitis b virus shows evidence of declining prevalence due to hepatitis b vaccination in central china

[86] seroprevalence of hepatitis b virus infection and associated factors among prison inmates in state of mato grosso do sul, brazil soroprevalência e fatores associados à infecção pelo vírus da hepatite b em população encarcerada no estado do mato grosso do sul, brasil

[87] the efficacy of lamivudine in the treatment of reactivation of chronic hepatitis b virus infection in patients on immunosuppressive therapy

[88] vanishing tumor in a liver graft from a hepatitis b virus surface antigen-positive donor

[89] immunoprophylaxis of hepatitis b virus infection

[90] hepatitis b virus and human immunodeficiency virus infections are a public health problem even in rural communities of vellore district, tamil nadu

[91] clinical and epidemiological aspects of hepatitis b virus and hepatitis c virus in fortaleza-ceara

[92] management and treatment of hepatitis b virus in patients with hiv infection: a practical guide for health care professionals

[93] antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis b virus infected patients

[94] corrigendum to “an increased ratio of glycated albumin to hba1c is associated with the degree of liver fibrosis in hepatitis b virus-positive patients”

[95] hepatitis b virus-related glomerulonephritis: not a predominant cause of proteinuria in korean patients with chronic hepatitis b

[96] complete remission of nephrotic syndrome of hepatitis b virus-associated membranous glomerulopathy after lamivudine monotherapy

[97] hepatitis b virus surface antigen variants clustered within immune epitopes in chronic hepatitis b carriers from hormozgan province, south of iran

[98] maternal transmission risk and antibody levels against hepatitis b virus e antigen in pregnant women

[99] Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy

[100] The Impact of Hepatitis B Vaccine Failure on Long-term Natural Course of Chronic Hepatitis B Virus Infection in Hepatitis B e Antigen–Seropositive Children

[101] Clinical Predictors of Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection From Children to Adults